共 50 条
- [1] Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open-label trial[J]. DIABETES OBESITY & METABOLISM, 2011, 13 (12): : 1149 - 1157Koivisto, V.Cleall, S.Pontiroli, A. E.Giugliano, D.
- [2] Randomised open-label trial of insulin lispro protamin suspension versus insulin glargine once daily in basal-bolus therapies with insulin lispro in type 2 diabetes patients[J]. DIABETOLOGIA, 2011, 54 : S421 - S422Giugliano, D.Cleall, S.Pontiroli, A. E.Koivisto, V.
- [3] A Comparison of CV-FBG in T2DM with Use of Glargine/NPH as a Basal Insulin[J]. DIABETES, 2010, 59 : A174 - A174Mu Pan-WeiZeng Long-YiZhang Guo-ChaoChen Yan-MingFu Jing-YiWang Man-Man
- [4] Comparison of the soluble basal insulin analog insulin detemir with NPH insulin - A randomized open crossover trial in type 1 diabetic subjects on basal-bolus therapy[J]. DIABETES CARE, 2001, 24 (02) : 296 - 301Hermansen, KMadsbad, SPerrild, HKristensen, AAxelsen, M
- [5] Optimizing Basal-Bolus Therapy in T2D-A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch vs. an Insulin Pen[J]. DIABETES, 2018, 67Bergenstal, Richard M.Peyrot, MarkDreon, Darlene M.Aroda, VanitaBailey, Timothy S.Brazg, Ronald L.Frias, Juan P.Johnson, Mary L.Klonoff, David C.Kruger, Davida F.Ramtoola, ShenazRosenstock, JulioSerusclat, PierreWeinstock, Ruth S.Naik, Ramachandra G.Shearer, David M.Zraick, VivienLevy, Brian L.
- [6] Transitioning T2DM Patients to Basal-Bolus Insulin Leads to Sustainable A1C Improvement[J]. DIABETES, 2019, 68Barry, RomiyaJohns, DonRees, Buddug
- [7] Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial[J]. LANCET, 2012, 379 (9825): : 1498 - 1507Garber, Alan J.King, Allen B.Del Prato, StefanoSreenan, SeamusBalci, Mustafa K.Munoz-Torres, ManuelRosenstock, JulioEndahl, Lars A.Francisco, Ann Marie OcampoHollander, Priscilla
- [8] Transfer of patients with type 1 diabetes from NPH insulin to insulin glargine as basal insulin: A multicenter, randomized, parallel-group open-label study[J]. DIABETES, 2006, 55 : A479 - A479Bolli, Geremia B.Songini, MarcoTrovati, MariellaDel Prato, StefanoGhirlanba, GiovanniCordera, RenzoTrevisan, RobertoRiccardi, GabrieleNoacco, Claudio
- [9] Comparison of Insulin Detemir and Insulin Glargine in a Basal-Bolus Regimen, With Insulin Aspart as the Mealtime Insulin, in Patients With Type 1 Diabetes: A 52-Week, Multinational, Randomized, Open-Label, Parallel-Group, Treat-to-Target Noninferiority Trial[J]. CLINICAL THERAPEUTICS, 2009, 31 (10) : 2086 - 2097Heller, SimonKoenen, ChristophBode, Bruce
- [10] Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed-Ratio Combination vs. Insulin Glargine in Japanese Patients with T2DM[J]. DIABETES, 2019, 68Kaneto, HideakiTakami, AkaneSpranger, RobertAmano, AtsushiWatanabe, DaisukeNiemoeller, Elisabeth